VKTX, GPCR, ALT stocks jump after Novo Nordisk M&A signal
Novo Nordisk said it could pursue larger acquisitions while targeting more than five “multi-blockbuster” launches by 2030, lifting smaller obesity players: Viking Therapeutics gained nearly 4%, Structure Therapeutics rose more than 5%, and Altim…
Shares of smaller obesity drug developers climbed on Monday after Novo Nordisk (NVO) said it could pursue larger acquisitions and is targeting more than five “multi-blockbuster” launches by 2030. Viking Therapeutics (VKTX) gained nearly 4%, Structure Therapeutics (GPCR) rose more than 5% and Altim…